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The mammalian hindlimb central pattern generator (CPG) for locomotion is located in 
the lumbar spinal cord, and coordinates contralateral alternation of the hindlimbs and 
intralimb flexor/extensor muscle alternations. Serotonin (5HT) plays an important role in 
enabling CPG functionality. All serotonergic input to the lumbar cord descends from the 
medullary Raphe nuclei; these inputs are lost after a complete spinal cord lesion. We used 
immunohistochemical methods to determine whether spinal cord injury (SCI) affects the 
expression levels of 5HT2C receptor clusters and CaV 1.3 channel clusters. Quipazine is a 
5HT2 agonist and its regular administration has previously led to partial locomotor 
recovery. We sought to determine if daily administration would reduce the SCI-induced 
homeostatic changes in 5HT2C receptor and CaV 1.3 channel levels. Half the SCI mice 
were treated with quipazine, and half were saline vehicle treated. A combination of 
ImageJ and Matlab was used to determine the number, size, and intensity of 5HT2C 
receptor clusters after SCI, as well as the percentage of the frame area covered by CaV 1.3 
channels and their average brightness. After SCI, there is a significant upregulation in the 
number of 5HT2C receptor clusters, and 5HT2C receptor clusters are significantly larger. 
Neither is reduced by quipazine. There is no significant change in the average brightness 
of 5HT2C receptor clusters after SCI. Additionally, the area and intensity of CaV 1.3 
channels are significantly larger in SCI/saline mice than in intact mice. CaV 1.3 channels 
were not examined in SCI/quipazine mice due to a small sample size.  
 
 
Introduction 
 
All animals exhibit some type of locomotor rhythmicity, such as respiration, chewing, 
digestion in the gastrointestinal tract, swimming, or walking, which is not controlled 
consciously. To generate rhythmic locomotor outputs, the central nervous system must 
have some internal driving rhythm. Typically, rhythmic locomotor outputs are controlled 
by a central pattern generator (CPG), a network of neurons that can have very complex 
excitation and inhibition circuits. CPGs can be composed of many types of neurons with 
different intrinsic properties and sensitivities to various neuromodulators, and the   3
presence of many types of neurons can generate relatively complex rhythmic locomotor 
outputs.  
  The mammalian hindlimb CPG for locomotion is responsible for coordinating 
left/right alternation of the hind limbs, as well as the flexor/extensor muscle alternations 
in each limb required to make a step, and these alternations occur in the absence of 
sensory inputs (Kiehn 2006). The hindlimb locomotor CPG is distributed through the 
lower thoracic and lumbar segments of the spinal cord, but is primarily concentrated in 
the upper lumbar region of the spinal cord (Kiehn 2006). This CPG involves a complex 
network of neurons that can generate rhythmic activity in the absence of sensory inputs, 
although sensory inputs can alter locomotor output (Kiehn 2006; Harris-Warrick 2010). 
  The hindlimb CPG receives serotonergic input from descending serotonergic 
fibers in the Raphe nuclei of the brainstem (Ballion et al. 2002; Jordan et al. 2008). 
Application of serotonin (5-hydroxytryptamine or 5HT) and NMDA (N-methyl-D-
aspartate) to whole cord preparations of the isolated neonatal mouse spinal cord can 
produce fictive locomotion that possesses the necessary criteria for locomotion: left/right 
interlimb alternation as well as intralimb flexor/extensor muscle alternation (Zhong et al. 
2010). 5HT plays a complex but not fully understood role in generating locomotor 
outputs (Schmidt and Jordan 2000). 5HT is known to increase motoneuron excitability 
(McCall and Aghajanian 1979); however, its actions are likely indirect as 5HT only 
produces a subthreshold depolarization of motoneurons in the absence of glutamate 
(VanderMaelen and Aghajanian 1980; Jackson and White 1990; White and Neuman 
1983). Likely, it plays a modulatory role, “priming” the CPG so that it can respond to   4
glutamatergic input that activates motoneurons to generate to locomotor output (Schmidt 
and Jordan 2000). 
  When the neuromodulatory inputs to hindlimb locomotor CPG neurons are 
disrupted, homeostatic changes to these neurons can be expected to occur to counter the 
change in neuromodulator levels. Homeostasis is a general principle of biology; the body 
responds to changes in its environment by opposing those changes, so that body 
conditions remain constant. When there is a decrease in concentration of a 
neurotransmitter within the central nervous system, receptors that normally bind that 
transmitter will typically increase expression levels to account for its decreased 
concentration. Theoretically, homeostasis is maintained, as there is less neurotransmitter 
but more receptors. However, an increase in receptor expression levels is not always 
desirable, as in the case of spinal cord injury (SCI). 
  One result of SCI is a partial or complete loss of descending serotonergic 
projections from the Raphe nuclei to regions of the spinal cord caudal to the injury site 
(Cormier et al. 2010; Ballion et al. 2002). Thus, as SCI reduces or eliminates, depending 
on how complete the lesion is, 5HT in regions caudal to the injury site, it can be expected 
for homeostatic changes to occur in neurons caudal to the injury that have 5HT receptors 
or channels. Li et al. (2007) found that motoneurons from SCI rats are sensitive to 
concentrations of 5HT that are subthreshold for motoneurons from non-injured rats. In 
SCI rats, these small 5HT concentrations led to higher amplitude persistent inward 
calcium currents in the motoneurons as compared to intact rats. The authors hypothesize 
that the muscle spasticity that occurs in humans, rats and mice with spinal cord injuries 
could be partially explained by this hypersensitivity to 5HT and larger inward calcium   5
current, which leads to more activation of the motoneurons. As there are still small 
amounts of endogenous 5HT in the body, a small amount caudal to the injury site can 
activate super-sensitive motoneurons and cause spasticity (Li. et al. 2007). Another 
homeostatic change at the neural level that can contribute to muscle spasticity is 
expression of constitutively active 5HT receptors. Murray et al. (2011) found that there 
are more constitutively active 5HT2C receptors in motoneurons after SCI than in 
motoneurons from non-injured rats. The authors suggest that having more constitutively 
active 5HT2C receptors could contribute to motoneuron over-activation and thus muscle 
spasticity, as neurons with constitutively active 5HT receptors can be active in the 
absence of 5HT (Murray et al. 2011) 
  In our lab, we have found that Chx-10 interneurons, which are hypothesized to 
play a role in generating left-right alternation in the locomotor CPG and are located 
ventral to the central canal (Zhong et al. 2010), are hypersensitive to 5HT after SCI 
(Husch, unpublished data). Chx-10 interneurons from SCI mice typically respond with at 
least 1-2 Hertz firing with 0.1 µm 5HT, while Chx-10 interneurons from intact mice 
typically do not respond with 0.1 µm 5HT. With 1 µm 5HT, intact neurons respond 
weakly (0-1 Hz), while SCI neurons respond strongly (8-9 Hz), and with 10 µm 5HT, 
intact neurons increase firing (1-2 Hz) while SCI neurons maintain a high firing 
frequency (8-9 Hz) (see Fig. 12 for sample recordings). In summary, Chx-10 interneurons 
from SCI mice respond to smaller concentrations of 5HT than interneurons from intact 
mice; Chx-10 interneurons are more sensitive to 5HT after SCI. This 5HT sensitivity is 
likely due to a combination of homeostatic changes that occur after SCI.    6
  In addition to electrophysiological experiments, various immunohistochemical 
experiments have examined the effect of SCI on the expression levels of 5HT receptors 
and channels that respond to 5HT in regions caudal to the lesion site. Hayashi et al. 
(2010) found SERT (5HT transporter) expression levels to be significantly decreased 
caudal to the injury site after both moderate and severe spinal cord contusions. Because 
SERT is responsible for the reuptake of 5HT following synaptic transmission and is thus 
found on synaptic boutons, the loss of serotonergic fibers following SCI may lead to 
degradation of SERT (Hayashi et al. 2010). SERT degradation may also contribute to 
neural 5HT sensitivity after SCI; if neurons are activated by small amounts of 
endogenous 5HT, there are no transporters to recycle it, leading to over-activation of 
neurons that respond to 5HT. Hayashi et al. (2010) also found a significant upregulation 
in 5HT2C receptors in the sub-lesional ventral spinal cord after severe spinal cord 
contusion. 5HT2C receptor upregulation is yet another mechanism for 5HT sensitivity; 
small concentrations of 5HT can activate neurons with a large upregulation of 5HT 
receptors.  
  One goal of spinal cord injury research is to reduce the negative effects, such as 
muscle spasticity, of the homeostatic changes that occur after SCI. Various combinations 
of 5HT receptor subtype agonists have been administered to SCI experimental animals in 
order to determine which combinations of receptor subtype activations are most effective 
at providing functional recovery. Daily administration of quipazine, a 5HT2 agonist, has 
been shown to induce partial locomotor recovery after SCI in rats (Antri et al. 2002; Ung 
et al. 2008). SCI mice receiving vehicle administration lose the ability to exhibit hindlimb 
plantar stepping, meaning they are unable to place the plantar surface of the foot in   7
contact with the ground. SCI mice receiving quipazine, however, exhibited partial plantar 
stepping, so that the plantar surface made some contact with the ground (Antri et al. 
2002). However, more successful locomotor recovery is possible with a combination of 
quipazine and 8-hydroxy-(2-di-N-propylamino)-tetralin or 8-OHDPAT; a 5HT1A and 
5HT7 agonist (Antri et al. 2005). Antri et al. (2005) found that with this treatment, 
locomotor performance did not decline after treatment was stopped, a promising result 
for treatment of SCI in humans.  
  My goal was to determine the expression levels of 5HT2C receptors and CaV 1.3 
channels after SCI in mice, using immunohistochemistry to observe the region of the 
spinal cord ventral to the central canal, where Chx-10 interneurons are located. As our lab 
has observed 5HT hypersensitivity in these interneurons after SCI using perforated patch 
electrophysiology, I sought to determine whether there was an upregulation of 5HT2C 
receptors, which could contribute to the 5HT sensitivity. Additionally, I examined CaV 
1.3 channel expression after SCI, as increased activation of calcium channels has been 
shown to occur in motoneurons after SCI (Li et al. 2007). Because daily quipazine 
administration leads to partial locomotor recovery after SCI, I also wanted to determine 
whether quipazine counters the homeostatic changes in 5HT2C receptor expression that 
occur in response to SCI.  
  I found that after SCI, both with and without daily quipazine administration, there 
is a significant upregulation in the number of 5HT2C receptor clusters. Additionally, 
5HT2C receptor clusters are, on average, significantly larger in SCI mice as compared to 
intact mice. There is no significant difference between the average brightness of 5HT2C 
receptor clusters between intact, SCI/saline or SCI/quipazine mice. After SCI without   8
quipazine, the area and intensity of CaV 1.3 channels are significantly larger than area and 
intensity in intact mice. CaV 1.3 channels were not examined in SCI/quipazine mice due 
to a small sample size. 
Materials and Methods 
 
Spinal cord injury surgery. 21-day old, Chx10/eCFP mice were anesthetized with 
ketamine/xylazine IP (0.01 mg/g ketamine, 0.005 mg/g xylazine; intraperitoneal). The 
dorsal side was then shaved and sterilized with 70% ethanol and betadine. 0.5% lidocaine 
(0.1cc), lactated Ringer’s (containing sodium lactate) (0.025 cc/g), and buprenorphine 
(0.1 mg/g) were administered subcutaneously. Using aseptic techniques, an incision was 
made dorsally above the thoracic region of the spinal cord, and layers of fat and muscle 
were separated to expose the vertebral column. Using forceps, a gap was made between 
the T8 and T9 vertebrae, and scissors were used to completely transect the spinal cord 
transversally. The muscles and fat were put back in place, and the incision was closed 
using tissue glue. 0.01 mg ketoprofen was administered IP, and mice were placed in a 
heated cage for at least 30 minutes for recovery. The entire procedure, from initial 
ketamine/xylazine administration to recovery, lasted approximately one hour. As a 
control for spinal cord injury (SCI) surgery, the surgical procedure described above was 
carried out on mice until the vertebrae were exposed, upon which the incision was closed 
with tissue glue (referred to as intact mice). Every subsequent day after surgery, half of 
the SCI mice received once daily quipazine IP (0.025 mg/g; referred to as 
SCI/quipazine), and half of the SCI mice received once daily saline (vehicle control; 
referred to as SCI/saline) IP. Additionally, all mice (intact and SCI) received the   9
analgesics buprenorphine (IP) for two days after surgery and ketoprofen (IP) for six days 
after surgery. Mice were euthanized for perfusion 28-35 days after surgery. 
  Perfusion and spinal cord fixation. Four weeks after SCI surgery, the intact and 
SCI mice were sacrificed for perfusion. Mice were anesthetized with an overdose of 
ketamine/xylazine (0.03 mg/g ketamine; 0.015 mg/g xylazine), and the perfusion was 
started once mice were no longer responsive to a foot pinch. Mice were placed, with the 
ventral surface exposed, under a fume hood. An incision was made into the peritoneal 
cavity up to the sternum. The ribcage was cut laterally on the left and right sides, and the 
diaphragm was cut so that the ventral portion of the ribcage could be removed. An 
incision was made in the right atrium, and a needle attached to a perfusion pump with 
perfusion buffer running was inserted in the left ventricle. Mice were perfused with 
perfusion buffer for three minutes, and then 4% paraformaldehyde (PFA) in 0.1 M 
phosphate buffer for 20 minutes. Mice were then eviscerated, a laminectomy performed, 
and the spinal cord removed from the vertebrae. 
  The L1-L2 (upper lumbar) region of the cord was placed in a 4% PFA, 0.1 M 
phosphate buffer solution for 1.5 hours at 4
oC, then transferred to 30% sucrose solution 
for 12 hours at 4
oC. 
  Immunohistochemistry. A cryostat was used to make 15 µm transverse sections of 
the L1-L2 region of one intact, one SCI/saline and one SCI/quipazine mouse (depending 
on which mice survived four weeks after SCI surgery), all of the same age and surgery 
date, placed on a single slide (see Fig. 1 for typical example of finished slide). The slides 
used were Thermo Scientifics’ SuperFrost Plus positively charged slides; negatively 
charged tissue can strongly adhere to the slides, which allows for more rigorous washes.   10
30 µm coronal sections of the lesion site (cervical and thoracic regions) were also made 
to ensure completeness of the lesion. Slides were stored at -20
oC for up to one week 
before immunohistochemistry.   
 
A 
 
B 
 
Figure 1. Orientation of tissue on slides. A, one position on a slide. B, entire slide with eight positions. 
Each position consists of 15 µm transverse sections of the spinal cord, from intact, SCI/saline and/or 
SCI/quipazine mice, depending on which mice survived four weeks after SCI surgery.  
 
  A pap pen was used to enclose each of the eight positions on the slide (see Fig. 1). 
At room temperature, slides were rinsed in a phosphate buffered saline (PBS) bath for 
five minutes. Then, slides were incubated in 0.2% Triton X-100 for 10 minutes. Slides 
were again rinsed with PBS for 15 minutes (for all PBS rinses, 15 minutes = three washes 
of five minutes each, changing the bath every five minutes). Slices were incubated in 
peroxidase quenching buffer for 60 minutes at room temperature, and then 1% blocking 
reagent (source unspecified by manufacturer) for 60 minutes at room temperature. Seven 
positions were incubated in one primary antibody (5-HT2C 1:200, ABcam; SERT 1:100, 
Immunostar; 5-HT 1:5000, Sigma; or CaV 1.3 1:200, Millipore; all diluted in 1%   11
blocking reagent), with one position only incubated in 1% blocking reagent (no primary 
control), for 16 hours at 4
oC. Slides were rinsed in 4
oC PBS for 15 minutes. Slices were 
then incubated in secondary antibody conjugated horseradish peroxidase (HRP) diluted 
1:100 in 1% blocking solution for 45 minutes at room temperature, and rinsed in PBS for 
15 minutes. Slides were then incubated in Alexa-Fluro 647 tyramide, diluted 1:100 in 
amplification buffer/0.0015% H2O2, for 16 minutes. Slides were rinsed in PBS for 15 
minutes, mounted with Fluor-Gel and cover-slipped. This tyramide amplification 
technique is explained in Fig. 2. 
 
 
Figure 2. Tyramide amplification mechanism. Unlike conventional immunofluorescence, tyramide 
immunofluorescence allows for signal amplification. The secondary antibody is conjugated to horseradish 
peroxidase (HRP), which reacts with an inactive tyramide derivative to produce a fluorescent tag bound to 
the secondary antibody. This HRP-derivative reaction occurs multiple times at each secondary antibody 
site, amplifying the signal at each antigen. Tyramide amplification is useful where there is high background 
noise or few antigen targets. Figure from Invitrogen instruction manual. 
 
 Confocal  microscopy. A Leica TCS SP2 confocal microscope was used for 
imaging. A 20-X objective lens was used to view tissue, and boxed regions (8-X zoom) 
of medial lamina VIII were imaged for analysis (see Fig. 3) using the 633 nm laser line.   12
Z-series were taken through the 15 µm tissue with the 633 nm laser in one µm steps. 
ImageJ was used to compile each image stack into a projection with the maximal 
recorded intensity at each z position displayed in the composite image (max projection).  
 
 
Figure 3. 20-X view of transverse spinal cord section. Red boxes enclose the medial lamina VIII regions 
of either side of the cord. Both sides of the cord were imaged for analysis at 8-X zoom, for a final zoom 
value of 160-X.   
 
 Image  analysis. A combination of ImageJ and Matlab was used for image 
analysis. For 5HT2C immunohistochemistry, intact, SCI/saline and SCI/quipazine images 
were compared, with n=13 for SCI/saline to intact comparisons, n=5 for SCI/quipazine to 
intact comparisons, and n=3 for SCI/saline to SCI/quipazine comparisons. The number of 
receptor clusters, as well as the average size and intensity of receptor clusters per image 
was compared in the above three combinations of intact, SCI/saline and SCI/quipazine. 
For CaV1.3 immunohistochemistry, intact and SCI/saline images were compared (n=4 
experiments). SCI/quipazine was not included because there was only one case where the 
CaV 1.3 labeling was successful for SCI/quipazine mice. The percentage of the image   13
covered by calcium channels and the mean intensity of this area were compared for intact 
and SCI/saline mice. No analysis was done for SERT labeling, because of a small sample 
size (n=2 experiments). The details of the analysis steps are outlined in the results 
section, so as to more clearly depict the results of these analyses.  
 
Results 
 
Loss of serotonergic fibers after spinal cord injury  
 
After spinal cord injury, there is an almost complete loss of serotonergic fibers as 
compared to intact mice (Fig. 4).  
A. Intact, original     B. SCI, original  
confocal image             confocal image 
    
C. Intact, no primary             D. SCI, no primary  
antibody                                antibody 
    
Figure 4. 5HT immunohistochemistry: loss of serotonergic fibers after spinal cord injury. A, Immuno-
labeling of 5HT, which labels serotonin containing fibers, in intact mouse. B, Immuno-labeling of 5HT in 
SCI mouse. Serotonergic fibers are no longer present after SCI. C and D, No primary antibody images for 
intact and SCI mice, respectively. 
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5HT2C receptors after spinal cord injury in quipazine and vehicle treated mice  
 
To determine the number of 5HT2C receptor clusters in intact and SCI mice, the method 
used is depicted in Fig. 5 below. First, the original images (Fig. 5A, B, C) were 
deconvolved in ImageJ. Deconvolving reduces the blurring artifact produced by the 
confocal microscope. A fluorescent bead is imaged with the confocal, and the rings 
around the bead are confocal-produced artifact. This reference bead image is used to 
reduce similar noise in immunohistochemical images from the confocal, and the result is 
dimmer background noise and sharper edges of fluorescently labeled objects (Hutcheon 
et al. 2000) (see Fig. 5D, E, F). The deconvolution algorithm used was downloaded as a 
macro from the ImageJ website (rsbweb.nih.gov/ij/). The algorithm uses the bead 
reference image to remove the blur that is known to be an artifact of the confocal 
imaging. The “Find Maxima” function on ImageJ was then used to detect points on the 
deconvolved image. This function is dependent on the noise tolerance, which can be 
manually changed and visualized. The noise tolerance was adjusted for the intact image 
so that all noticeable points were detected, and this tolerance value was then used for any 
SCI/saline and/or SCI/quipazine images from the same experiment, so that the images 
could be compared. The output type of Find Maxima was set to single points, and a 
binary image with one pixel for each maxima found was the output (5J, K, L). The macro 
“Grid of ROIs” (written by Dr. Nathan Cramer; ROI=region of interest) was then run on 
the binary image. This macro divided the image into 16 equally sized boxes, and counted 
the number of pixels (corresponding to the number of maxima) within each box. The 
final output on each image gave the pixel count for each box, so that there were 16 
maxima values per image. This bin size allowed one image to be compared to another so   15
that a significant change in the number of maxima could be detected between intact and 
SCI conditions. A two-sided, unpaired t-test was used to compare the number of maxima 
between intact and SCI/saline, intact and SCI/quipazine, and SCI/saline and 
SCI/quipazine images. After p-values were obtained for each comparison in an 
experiment, the log of each p-value was taken, so that p-values could be averaged, as p 
values ranged from 0.02-5.26E-20. If multiple images were analyzed for one experiment, 
the logs of these p-values were averaged. Then, an overall average was taken, using one 
log of p-value per experiment, and this average was converted out of log form 
(10^average), giving an overall p-value for the change in number of receptors after SCI. 
The final result was an overall p value for the comparison of the number of maxima in 
intact vs. SCI/saline, intact vs. SCI/quipazine, and SCI/saline vs. SCI/quipazine. These p 
values are listed in Table 1, represented by (#). Significance for these three comparisons 
for each experiment is indicated in Fig. 6. It is important to note that only cords exposed 
to the exact same immunohistochemistry experiment and conditions were directly 
compared.  
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A. Intact, original     B. SCI/saline, original     C. SCI/quipazine, original 
 
D. Intact, deconvolved   E. SCI/saline, deconvolved  F. SCI/quipazine, deconvolved 
 
G. Intact, find maxima   H. SCI/saline, find maxima  I. SCI/quipazine, find maxima 
 
J. Intact, binary output     K. SCI/saline, binary output  L. SCI/quipazine, binary output 
119 points      210 points              200 points 
 
Figure 5. Finding maxima in ImageJ from intact (A, D, G), SCI/saline (B, E, H) and SCI/quipazine (C, F, 
I) mice. All images are 8 bit, 8-X zoom in medial lamina VIII (see Fig. 3), and are max projections of z-
series. A, B, and C, Original images from intact, SCI/saline, and SCI/quipazine mice, respectively. D, E 
and F, Deconvolved images of A, B, and C, respectively. G, H, and I, Corresponding images after a 
constant threshold is set for all images and the “Find Maxima” function in ImageJ is used. J, K, and L, 
Binary outputs from the “Find Maxima” function.  
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  Once an output for the total number of points in each image was generated for an 
experiment, all possible ratios comparing SCI/saline to intact, SCI/quipazine to intact, 
and SCI/saline to SCI/quipazine were calculated, depending on the mice surviving for 
each experiment. For the experiment shown in Fig. 5, the SCI/saline to intact ratio is 210 
points/119 points, or 1.76; the SCI/quipazine to intact ratio is 200/119, or 1.68; and the 
SCI/saline to SCI/quipazine ratio is 210/200 or 1.05. Typically, there were two images 
per mouse per experiment; when this was the case, the two ratios were averaged to give a 
resultant average. For each experiment, there was one average ratio for SCI/saline to 
intact, SCI/quipazine to intact, and/or SCI/saline to SCI/quipazine. The ratios for each 
experiment are shown in Fig. 6. These three types of ratios were averaged for all 
experiments, and the results are summarized in Table 1.  
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Figure 6. Ratios of number of points in 5HT2C labeling for SCI/saline to intact, SCI/quipazine to intact, 
and SCI/saline to SCI/quipazine comparisons by experiment. * indicates p < 0.05 when number of points in 
5HT2C labeled images in an image were compared within an experiment. In comparing two images, 
significance was obtained by dividing each image into 16 boxes (Grid of ROIs macro) and having a point 
count for each box. Blue indicates SCI/saline to intact comparison, red indicates SCI/quipazine to intact 
comparison, and green indicates SCI/saline to SCI/quipazine comparison.  
  
The SCI/saline to intact ratio across all experiments was significantly larger than 1 (Mean 
± SD: 2.2 ± 1.5; n=13), as was the SCI/quipazine to intact ratio (2.9 ± 1.5; n=6). The 
SCI/saline to SCI/quipazine ratio across experiments was not significantly different that 1 
(1.4 ± 0.4; n=3). These average ratios are shown in Table 1. 
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Table 1. Average ratios of number of points for three comparisons: SCI/saline to 
intact, SCI/quipazine to intact, and SCI/saline to SCI/quipazine. 
  SCI/saline to 
intact 
comparisons 
SCI/quipazine to 
intact 
comparisons 
 
SCI/saline to 
SCI/quipazine 
comparisons 
Mean of ratios of  # 
points ± SD 
2.2 ± 1.5*#; 
n=13 
2.9 ± 1.5*#; n=6 
 
1.4 ± 0.4; n=3 
*=average ratio across all experiments significantly larger than 1.0 (p=0.003 for 
SCI/saline to intact; p=0.02 for SCI/quipazine to intact; p=0.16 for SCI/saline to 
SCI/quipazine; unpaired Student’s t-test) 
 
#=significant difference obtained by combining p values from within experiment image 
comparisons (by using Grid of ROIs macro described above) (p=0.007 for SCI/saline to 
intact; p=0.004 for SCI/quipazine to intact; p=0.153 for SCI/saline to SCI/quipazine; 
unpaired Student’s t-test) 
 
  In addition to measuring the number of receptor clusters after SCI, a Matlab 
program developed by Adam McCann, a Master of Engineering student at Cornell 
University, was used to measure the pixel size and average intensity of each cluster or 
region of interest (ROI) (Fig. 7). First, the average intensity of the no primary antibody 
control image (Fig. 7B) was subtracted from the original image (Fig. 7A). Next, the 
subtracted images (Fig. 7C) were intensity thresholded, with the same threshold for all 
images to be compared (intact, SCI/saline, and/or SCI/quipazine) (Fig. 7D), and only 
pixels above this threshold are included in the next steps. Next, a morphological close 
operation is used to enforce the minimum blub radius of two pixels. Once the close 
operation is complete, a recursive region-growing algorithm is used to segment the ROIs 
and label each of the pixels in each ROI according to its assigned number. The resultant 
output is a mask structure that holds the ROI labels for the each of the pixels (Fig. 7E). 
Finally, the total number of pixels in each ROI as well as the total intensity value of each 
ROI is the calculated using the mask structure. Then, the total intensity of each ROI is 
divided by its area to obtain an “intensity density” value for each ROI.    20
A. 5HT2C immunohisto-     B. No primary antibody   C. Image B after subtraction   
  chemistry, original image      control       of no primary antibody  
    
 
D. Binary output after          E. Mask for 
    setting intensity threshold    image C 
     
Figure 7. Matlab analysis to determine the size and intensity of 5HT2C receptor clusters in intact, 
SCI/saline, and SCI/quipazine mice. First, the average intensity of the no primary antibody control (B) is 
subtracted from the original image (A), to adjust for tissue auto-fluorescence and non-specific binding of 
the secondary antibody. The resultant image (C) then has an intensity threshold applied in Matlab (D), and 
a minimum cluster radius is set for identifying regions of interest. The program uses a morphological close 
operation to remove regions under the cluster radius restriction, and then segments them to give a labeling 
mask structure for the deconvolved, no primary subtracted image (E).  
 
  A sample of the results from one experiment is shown in Fig. 8. Fig. 8A shows 
the area (in pixels) of each cluster found using the described Matlab program versus the 
cluster or ROI (region of interest) number assigned by the program for the intact mouse 
image. The maximum area for this image is 169 pixels, the mean area of the ROIs is 37 
pixels, and 42 ROIs were found. Fig. 8B-C show ROI area results for an SCI/saline and 
an SCI/quipazine image from the same experiment, respectively. For the SCI/saline 
image (Fig. 8B), the maximum ROI area is 11683 pixels, the mean ROI area is 309 
pixels, and 228 ROIs were found. For the SCI/quipazine image (Fig. 8C), the maximum   21
ROI area is 15968 pixels, the mean ROI area is 289 pixels, and 67 ROIs were found. In 
summary, for the example shown in Fig. 8A-B, the average area of the intact ROIs was 
smaller (37 pixels) than the average ROI areas for the SCI/saline (309 pixels) and 
SCI/quipazine (289 pixels) images. Additionally, the SCI/saline image had the most ROIs 
(228), while the intact had the least (42). After the average area of ROIs for each mouse 
was obtained, the average ROI areas for each experiment were compiled, and paired 
Student’s t-tests were done to compare intact, SCI/saline, and SCI/quipazine average 
areas. The average areas and intensity densities from each experiment are shown in Fig. 
9. For eight out of nine experiments, the average ROI area in SCI/saline mice was greater 
than that of intact mice of the same experiment, and the overall mean of ROI average 
areas across all experiments was significantly larger in SCI/saline (mean from all 
experiments=123 pixels; SD=84) as compared to intact; see Table 2 (mean from all 
experiments=65 pixels; SD=40) (n=9; p=0.046; Student’s paired t-test). In comparing 
intact to SCI/quipazine, there was no significant difference in the mean area (intact 
mean=48 pixels, SD=31; SCI/quipazine mean=132 pixels, SD=101; n=5; p=0.13; paired 
Student’s t-test). These results are summarized in Table 2. A paired t-test was done 
because of the variability between experiments; the same gain and laser power on the 
confocal was not used for each experiment, and the duration of the primary antibody 
incubation varied from 12-16 hours. Direct comparisons between experiments would be 
unreliable for these reasons. 
  A sample experimental output for the ROI “intensity density” is shown in Fig. 
8D. There is much less variability between mice for these values; the mean intensity 
density of the ROIs is 226 for intact, 225 for SCI/saline, and 226 for SCI/quipazine. The   22
maximum ROI intensity density for intact was 231, 230 for SCI/saline, and 231 for 
SCI/quipazine. The means for all experiments were compiled in the same way the means 
for the areas were (see Fig. 9B for average intensity density values for each experiment). 
There were no significant differences between any groups across experiments.  
 
A. Area of all ROIs within an                           B. Area of all ROIs within an SCI/saline  
intact image                                                       image 
 
 
 
C. Area of all ROIs within an                          D. Intensity densities (intensity    
SCI/quipazine image                                        values per area) of all ROIs; intact, 
                                                                          SCI/saline, and SCI/quipazine combined                           
 
Figure 8. Area and intensity data from one experiment (intact, SCI/saline and SCI/quipazine). A-C, Area 
(in pixels) of each ROI for intact, SCI/saline, and SCI/quipazine, respectively. The intact image has less 
ROIs than the SCI images, and the average area for intact is smaller than for SCI/saline or SCI/quipazine. 
The maximum ROI area for the intact image is less than 180 pixels (A), while most of the ROIs for 
SCI/saline and SCI/quipazine range from 0-2000 (B) and 0-500 (C), respectively. D, Intensity density 
values for each ROI in intact, SCI/saline and SCI/quipazine from one experiment. These vales are closer to 
each other than the area values for intact, SCI/saline and SCI/quipazine. Blue represents intact mice, red 
represents SCI/saline mice, and green represents SCI/quipazine mice.  
 
  A summary of the results of the average 5HT2C receptor cluster areas and 
intensity density values across all experiments is shown in Fig. 9 and Table 2.     23
A. Average area of clusters in intact, SCI/saline and SCI/quipazine mice, by experiment 
 
B. Average intensity density of clusters in intact, SCI/saline and SCI/quipazine mice, by 
experiment 
 
 
Figure 9. Summary of average area and intensity density of 5HT2C receptor clusters by experiment. A, 
Average pixel area of clusters (using the Matlab program described in the text) for each mouse in each 
experiment. B, Average intensity density of clusters for each mouse in each experiment. Blue represents 
intact mice, red represents SCI/saline mice, and green represents SCI/quipazine mice. 
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Table 2. Summary of 5HT2C cluster areas and intensity densities across experiments 
 Intact  (n=11)  SCI/saline 
(n=10) 
SCI/quipazine 
(n=5) 
Mean area of 
clusters ± SD 
65 ± 40  123 ± 84*  132 ± 100 
Mean intensity 
density of clusters ± 
SD 
126 ± 62  136 ± 59  149 ± 60 
*significantly different from intact (p=0.046, Student’s t-test) 
 
  After spinal cord injury with no quipazine administration, 5HT2C
 receptor clusters 
significantly increase in number and average area, but not average intensity density. 
There is no significant difference in the ratio SCI/saline # points to SCI/quipazine # 
points, indicating that daily quipazine administration does not have a significant effect on 
the number of 5HT2C receptors after spinal cord injury.  
 
CaV 1.3 channels after spinal cord injury in quipazine and vehicle treated mice  
 
ImageJ was used to analyze CaV 1.3 images. Two types of measurements were obtained: 
a binary count of how many pixels were above a set threshold (Fig. 10I-J), and a measure 
of the mean intensity of the labeling that was above this threshold (Fig. 10K-L). Images 
were deconvolved as described for the 5HT2C immuno-labeled images, and the average 
intensity of the deconvolved no primary antibody image was subtracted out (Fig. 10A-H). 
Then, ImageJ was used to automatically set a threshold for the intact image, and this 
same threshold was used for SCI images to be compared to intact. No SCI/quipazine 
images were analyzed, as there was only one experiment where the CaV 1.3 labeling was 
successful and an SCI/quipazine mouse was available. Once the threshold was set, a 
binary image was created, with black pixels above the threshold, and white pixels below 
the threshold (Fig. 10I-J). The percentage area of the image that was taken up by labeling 
could then be determined. Percentages for intact and SCI were compared; if there was   25
more than one image per intact or SCI mouse within an experiment, all percentages were 
averaged to give one mean percentage per mouse per experiment. A paired Student’s t-
test (n=4 experiments) was used to compare intact to SCI percentages across 
experiments, as percentage could vary between experiments are a result of different 
intensity settings on the confocal laser, different degrees of antibody washes during 
immunohistochemistry, and the exact length of time tissue was incubated in antibodies. 
However, these variables were kept exactly the same within an experiment, as SCI and 
intact tissues were directly adjacent on slides (see Fig. 1). A summary of the binary 
percentages for intact and SCI is shown in Table 3. 
  For the second component of the analysis, determining the average intensity of 
the pixels above threshold, the “Image Calculator” function in ImageJ was used to 
subtract the deconvolved, no primary subtracted image (8G-H) from the binary (resultant 
images: 8K-L). Histograms of the resultant images were done, and the mean intensities 
reported in Table 3. If more than one image was available per experiment for intact or 
SCI, the mean intensities were averaged for that mouse, so that only one mean intensity 
was given for each intact and SCI mouse within an experiment. As with the binary 
percentages, a paired Student’s t-test (n=4 experiments) was done to compare the mean 
intact intensity to the mean SCI intensity across experiments.  
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A. Intact, no 1º IgG         B. SCI, no 1º IgG          C. Intact, original image    
     
D. SCI, original image   E. Intact, deconvolved    F. SCI, deconvolved             
     
G. Intact, deconvolved   H. SCI, deconvolved     I. Intact, binary: 25% of   
and no 1º subtracted       and no 1º subtracted       pixels above threshold                     
     
J. SCI, binary: 27% of  K. Intact, G minus binary  L. SCI, H minus binary 
pixels above threshold    Mean intensity=45.6        Mean intensity=48.9 
   
Figure 10. ImageJ analysis of CaV 1.3 images. A-B, No primary antibody control images for intact and 
SCI, respectively. C-D, Z-projections of z-series taken from the confocal in 1 µm steps (total ranges from 
10-12 µm in a series) for intact and SCI, respectively. E-F, Corresponding deconvolved images. G-H, 
Corresponding results of subtracting the average intensity of the respective no primary images from the 
deconvolved images. I-J, Binary outputs of G and H, with the same intensity threshold set for both. Here, 
24.7% of the pixels are above threshold for intact, and 27.3% of the pixels are above threshold for SCI. K-
L, Result of subtracting the images in G and H (using the “Image Calculator” in ImageJ) from their 
respective binary images, giving the intensity values of all pixels above threshold. The mean intensity was 
45.6 for intact and 48.9 for SCI here.   27
Table 3. Summary of CaV1.3 analysis results.  
  Percentage of pixels above 
threshold (n=4 mice, 8 
images) 
Mean intensity value of 
pixels above threshold 
Intact, mean ± standard 
deviation 
21.8 ± 0.09  46.5 ± 24.0 
SCI, mean ± standard 
deviation 
36.4 ± 0.15  72.6 ± 39.9 
p value (paired Student’s t-
test) 
0.028   0.047  
 
  The results of the CaV1.3 analysis are shown in Table 3. In the binary images, 
there was a significantly higher percentage of pixels above threshold in the SCI condition 
(36.4 ± 0.15) as compared to intact (21.8 ± 0.09) (n=4; paired Student’s t-test; p=0.028). 
When the binary images were subtracted from the original images, the mean intensity 
was significantly higher in the SCI (72.6 ± 39.9) images as compared to intact (46.5 ± 
24.0) (n=4; paired Student’s t-test; p=0.047). All images used were 16-bit, and intensity 
values range from 0 (black) to 4095 (white, saturation).  
 
Distribution of the serotonin transporter after spinal cord injury in quipazine and 
vehicle treated mice  
 
As there was only an n of two experiments, no analysis was done on the serotonin 
transporter immunohistochemistry. One result is shown in Fig. 11, along with the no 
primary antibody controls.  
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A. Intact original image        B. SCI original image 
   
C. Intact, no primary             D. SCI, no primary  
antibody               antibody 
   
Figure 11. Example of serotonin transporter (SERT)
 labeling (unaltered images), taken from medial 
lamina VIII of spinal cord (Fig. 3). Images are z-projections of z-series, as in Fig. 5A-B, with 10-12 µm of 
tissue imaged in 1 µm steps. A, intact mouse. B, SCI/saline mouse. C-D, No primary antibody controls for 
intact and SCI/saline, respectively. All four images were obtained with the exact same confocal settings.  
 
Discussion 
 
After spinal cord injury, there is a significant upregulation in the number of 5HT2C 
receptor clusters, both with and without quipazine administration. The average area of 
these receptor clusters is larger after SCI, significantly larger for SCI/saline but not 
significant for SCI/quipazine.   
  Because spinal cord injury cuts off the descending serotonergic input from the 
Raphe nuclei, neurons caudal to the lesion site no longer receive serotonergic input. A 
loss of 5HT would be expected to cause homeostatic changes to adjust to this loss. For 
example, neurons with 5HT receptors may increase receptor expression in order to 
become activated by a smaller amount of 5HT. Intact mice have 5HT2C receptors   29
throughout the gray matter of the upper lumbar spinal cord, and in the ventral half of the 
cord, these receptors are post-synaptic (not autoreceptors) (Schmidt and Jordan 2000). 
Because 5HT2C receptors have post-synaptic functions in the medial lamina VIII region 
of the upper lumbar spinal cord, we would expect there to be a homeostatic upregulation 
in the expression levels after SCI. Using ImageJ, there was a significant increase in the 
number of 5HT2C receptors. This increase in the number of receptors may represent new 
sites of 5HT2C on dendrites. Additionally, we found that the average area of 5HT2C 
receptor clusters after SCI (no quipazine) was significantly larger than the average area of 
receptor clusters in intact mice within each experiment. This increase in the area of 
receptor clusters after SCI could mean that at each receptor cluster, there is an increased 
expression of 5HT2C receptors. The average brightness of the clusters is not significantly 
different after SCI, and does not appear to trend towards any difference between groups. 
An increase in brightness could translate to a higher concentration of receptors at a given 
area, which we did not observe. Together, the area and intensity results suggest that after 
SCI, each cluster of 5HT2C receptors covers more area, but each cluster does not increase 
in density of 5HT2C expression. One possible explanation for this expression pattern is 
that in intact mice, there is already a maximal or optimal concentration of 5HT2C 
expression at each cluster, and there is simply not enough room on the membrane to 
increase the density of 5HT2C expression after SCI.  
  Because there are more, larger, 5HT2C receptor clusters in spinal cord injured 
mice, as compared to intact mice, it may be expected for neurons with 5HT2C receptors to 
be more sensitive to 5HT after SCI. Electrophysiological experiments by Dr. Andreas 
Husch from our lab have shown that V2a interneurons, which are hypothesized to play a   30
role in the locomotor CPG and are located in the intermediate zone of the spinal cord, in 
intact mice are unresponsive to 0.1 µm 5HT, show weak excitation in 1 µm 5HT (firing 
frequency less than 1 Hz in the recording in Fig. 12), and the strongest excitation with 10 
µm 5HT (up to 2 Hz in the recording in Fig. 12). However, recordings from V2a 
interneurons from mice sacrificed four weeks after SCI surgery are strongly responsive to 
0.1 µm 5HT and higher, with firing frequency reaching 8 Hertz (Fig. 12) The same SCI 
surgery protocol is used for these mice as the protocol described in the Methods section 
above.  
 
 
Figure 12. “In SCI mice, V2a interneurons are 5HT supersensitive. A) Perforated Patch recording of a 
silent control V2a interneuron. Application of 0.1 µM 5HT did not change the activity of the interneuron. 
While application of 1 µM 5HT shows weak effects on activity, 10 µM 5 HT applications depolarizes the 
membrane potential and elicits 1-2 Hz firing (right). B) Perforated Patch recording of a silent SCI V2a 
interneuron. Application of 0.1 µM 5 HT depolarized the membrane potential and initiated tonic firing up 
to 4 Hz. (left) Application of 1 or 10 µM 5 HT lead to depolarization and AP firing at higher frequencies. 
The asterisks indicate the times of expanded views of the firing activity.” (Husch, unpublished data) 
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  We hypothesized that daily administration of quipazine, a 5HT2 agonist, may act 
as partial 5HT replacement therapy and reduce the upregulation of 5HT2C receptor 
clusters after SCI. However, we did not observe a reduction in upregulation of 5HT2C in 
SCI/quipazine mice as compared to SCI/saline mice; in fact, the mean ratios of the 
number of clusters in SCI/quipazine as compared to intact mice (2.6 ± 1.5) was slightly 
(though not significantly) larger than the ratio for SCI/saline to intact (2.2 ± 1.5) (Table 
1). Because there was still a significant upregulation of 5HT2C receptor clusters in SCI 
mice receiving daily quipazine administration, quipazine alone is insufficient to reduce 
5HT2C upregulation. Additionally, electrophysiological experiments from our lab have 
shown that V2a interneurons from SCI/quipazine mice show the same sensitivity to 5HT 
as SCI/saline mice do, responding with a high firing frequency and depolarization with 
0.1 µm 5HT (Husch, unpublished data). One reason for this maintained 5HT2C 
upregulation and 5HT hypersensitivity may be the nature of the administration, as mice 
receive quipazine once daily as an intraperitoneal injection. Thus, the concentration of 
quipazine in the spinal cord is likely not constant throughout the day, and its application 
does not mimic natural conditions, where 5HT levels rise and fall over the course of a 
day (Reiter 1976). To address this concern, a similar immunohistochemistry experiment 
could be done on SCI mice that receive quipazine via an implanted osmotic mini-pump 
that administers a fixed concentration directly to the spinal cord (Antri et al. 2003). 
Quipazine alone would not likely be used to treat humans with spinal cord injuries. It 
does not mimic the natural levels of 5HT in the spinal cord; to accurately regulate levels, 
administration would have to be timed precisely and likely occur fairly frequently. 
Additionally, quipazine is a 5HT2 agonist; there are other 5HT receptor subtypes in the   32
spinal cord that are involved in locomotion (Landry et al. 2006; Madriaga et al. 2004; 
Schmidt and Jordan 2000), and binding 5HT2 alone does not reduce 5HT sensitivity. As 
there was a significant upregulation of 5HT2C receptors in four out of five SCI/quipazine 
mice, another shortfall of quipazine is that it is not activating the homeostatic pathway 
that prevents 5HT2C upregulation after SCI, demonstrating its inability to mimic all of the 
actions of 5HT. Because quipazine did not reduce the upregulation of 5HT2C after SCI, 
and V2a interneurons from SCI/quipazine mice are sensitive to 0.1 µm 5HT, these 
neurons are still hypersensitive to 5HT. Quipazine alone does not seem to mediate 
homeostatic changes in 5HT2C receptor expression that occur after spinal cord injury.   
  Another result of spinal cord injury is a significant increase in the area and the 
intensity of the medial lamina VIII region covered by CaV 1.3 voltage-gated calcium 
channels (Table 3). An increase in the total area covered by CaV 1.3 channels could be the 
result of an increase in CaV 1.3 expression levels at more places on the dendrites, while an 
increase in the intensity could mean a higher density of CaV 1.3 channels at each site 
where the channels are found. CaV 1.3 channels are L-type channels, meaning that they 
facilitate a slow, but long-lasting inward current (Li et al. 2007; Bell et al. 2001). In 
normal neurons, CaV 1.3 channels mediate a voltage-dependent persistent inward calcium 
current that is activated by 5HT (Li et al. 2007). As CaV 1.3 channels respond to 5HT, 
and there is a 5HT loss following SCI, our hypothesis of homeostatic compensation 
would predict that CaV 1.3 expression levels would increase to compensate for 5HT loss. 
Together, the increase in area and intensity of CaV 1.3 channels following SCI point to an 
overall increase in the expression level of CaV 1.3 channels, another consequence of SCI 
that could contribute to V2a interneuron hypersensitivity to 5HT.    33
One consequence of spinal cord injury that impacts the quality of life for humans 
is involuntary leg muscle spasms. There are multiple changes at the neural and molecular 
levels that occur following SCI related to 5HT loss that could possibly contribute to this 
muscle spasticity. In addition to the hypersensitivity to 5HT in interneurons observed in 
our lab, Murray et al. (2011) found there to be an increase in the number of constitutively 
active 5HT2C receptors in rat motoneurons after SCI, meaning these motoneurons can 
become activated in the absence of 5HT. Thus, after SCI, neurons involved in producing 
locomotor output can respond to a lower than normal physiological concentration of 5HT 
or activate in the absence of 5HT (when they normally require 5HT to become activated). 
This general hyperactivity can partially explain why involuntary muscle spasms in SCI 
patients occur, and suggests routine administration of the right combination of 5HT 
agonists may help to reduce homeostatic changes that lead to 5HT sensitivity. Indeed, 
Guertin (2009) found that when SCI mice were regularly administered a cocktail of 
dopaminergic and serotonergic receptor subtype agonists, mice exhibited locomotor 
recovery and were able to take weight-bearing steps with plantar foot placement. Work is 
currently being done in the field to obtain an optimal treatment cocktail.  
  Our lab is currently exploring the effects of SCI on the distribution of the 
serotonin transporter (SERT). Its homeostatic changes after SCI may also contribute to 
5HT sensitivity in V2a interneurons as well as other serotonergic neurons. In intact mice, 
SERT, located along synaptic boutons of serotonergic fibers, removes 5HT from the 
synaptic cleft following synaptic transmission. After SCI, serotonergic fibers from the 
hindbrain degenerate along with SERT; thus, when neurons in the upper lumbar region 
are exposed to endogenous 5HT, there are fewer 5HT transporters to remove the 5HT   34
from the surrounding synaptic cleft. The increased firing frequency of SCI neurons 
shown in Fig. 12 could partially be explained by this loss of SERT; the effective dose of 
5HT would be larger for neurons from SCI mice as compared to intact mice because of 
the loss of SERT. If SERT loss is a contributing factor to 5HT sensitivity, then it should 
be possible for 5HT sensitivity to exist without an increase in the number of 5HT 
receptors. Our lab is currently exploring this hypothesis by applying citalopram, a SERT 
blocker, to V2a interneurons from intact mice and using perforated patch recordings to 
measure neural responses to 5HT (Husch, unpublished data). Blocking the 5HT 
transporters increases sensitivity to 5HT, indicating that a loss of SERT after SCI 
contributes to 5HT sensitivity. A future goal is to continue SERT immunohistochemistry 
experiments, like that shown in Fig. 11, to determine whether there is a loss of SERT 
after SCI. We also intend to analyze the 5HT2C images in 3D to compare volume and 
intensity densities of receptor clusters, to further understand the changes in receptor 
clusters following spinal cord injury. 
 
Conclusions 
 
The network of neurons that generates the rhythmic alternation of legs (in humans) and 
fore- and hindlimbs (in other animals) to produce walking is complex and not fully 
understood. A variety of neuromodulators play various roles in the activation of different 
neuron types, creating a complex circuit of excitation and inhibition. The CPG is not 
completely rigid, however; it must also have flexibility, as animals walk at different 
speeds and sensory feedback can influence locomotor output. It would follow that spinal 
cord injuries that occur anterior to this CPG disrupt normal communication between the 
brain as well as peripheral nerves anterior to the injury site. We cannot predict the   35
entirety of the effects SCI can have on the CPG, and thus cannot yet hope to reverse all of 
the effects of SCI once it occurs. However, we can elucidate specific components of the 
effects, and eventually put together a more complete picture. Here, we found that after 
SCI, the number and average size of 5HT2C receptor clusters increases, as well as the area 
and mean intensity of CaV 1.3 channels. Hayashi et al. (2010) found that SERT is down-
regulated after severe spinal cord contusions, and Murray et al. (2011) found that there 
are more constitutively active 5HT2C receptors after. Likely, many more receptor 
subtypes and channels are affected in different ways by SCI, and only by using multiple 
approaches such as immunohistochemistry and electrophysiology can we hope to 
elucidate all the effects of spinal cord injury, and how we can mediate those effects to 
increase quality of life. 
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